The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program’s ultimate success. Join this webinar to hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program.

Register Now

Key Learning Objectives:

Key Considerations for Tech Transfer Identification of critical material attributes (CMA), critical process parameter (CPP) and critical quality attributes (CQA) of drug product and how to predict their impact on a formulation and manufacturing processes Overview of primary processing technology in OSD manufacturing and how material characteristics dictate the unit operations method. Overview of Catalent’s Manufacturing Solutions